Fundraising and Financing France-UK: Choose, Secure, Convince

Raising capital is a decisive phase for a company's growth, whether it operates in Paris, London, or on both sides of the Channel. This guide breaks down:
- available funding sources in France and the UK;
- key legal points to anticipate for a successful raise;
- investor relations management via a shareholders' agreement.
-
Executive goal: optimize your company's value by securing every stage – from the term sheet to the exit.
1. Financing Options
1.1 Equity Funding
- Capital contribution : strengthening share capital by founders or existing shareholders.
- Business angels & VCs : early-stage tickets (Seed, Series A) providing capital and networking.
- Family offices & growth funds long-term investors to accelerate international expansion.
UK Focus: SEIS/EIS schemes offer investors up to 50% tax relief—a powerful incentive for attracting capital.
1.2 Debt Funding
- Bank loans amortizing or bullet, backed by collateral (share pledges, French state-guaranteed loans).
- Bonds plain vanilla or convertible (OCEANE, UK convertible loan notes) to combine debt and equity.
- Revenue-based financing and venture debt : flexible solutions for high-growth startups.
1.3 Alternative Instruments
- Crowdfunding (equity, loans, rewards) via AMF/FCA-regulated platforms.
- Leasing & factoring to optimize operating cash flow.
- Grants & tax credits : Bpifrance, Innovate UK, Horizon Europe.
1.4 France vs. England: comparison table

CriterionFranceUnited KingdomIncentive tax regimeIR-PME reduction, PEA-PMEEIS (50%), EIS (30%)Issuance formalitiesContribution auditor report, EGMCompanies House filing, SH01Closing speed6–12 weeks4–8 weeks
2. Key legal issues during a fundraising round
2.1 Due diligence
Investors audit: articles of association, cap table, intellectual property, key contracts, and litigation. Prepare a structured data room to save time and build trust.
2.2 Transaction structuring
- Valuation and dilution : negotiate pre-money, issue ordinary or preferred shares (BSPCE, preferred shares).
- Corporate law compliance : proper meeting notices, waiver of pre-emptive rights, and articles of association amendments.
- Documentation : term sheet → SPA / Subscription Agreement → shareholders' agreement.
2.3 Regulatory Compliance
StandardFranceUKPublic offeringsProspectus + AMF (EU Regulation 2017/1129)FSMA 2000 exemptions, FCA rulesAnti-money launderingDecree 2019-1213: KYC, register of beneficial ownersMoney Laundering Regulations 2017Post-closing reportingRegister of beneficial owners (RBE)PSC Register + filing Form SH01
2.4 Minority protection & anti-dilution
- Ratchet clauses, full/weighted average anti‑dilution.
- Pre‑emptive rights : pre‑emption, tag along, drag along.
- Liquidation preference : 1× non-participating standard, to be adjusted based on risk.
3. Investor Relations
3.1 Shareholders’ Agreement
Core contractual document specifying:
- Governance : board composition, quorum, veto rights.
- Share transfers : approval, lock-up, tag-along/drag-along rights.
- Founder commitments : vesting, non-compete, IP assignment.
- Exit process : IPO, M&A, share buy-back.
3.2 Reporting & communication
- Quarterly board packs (KPIs, cash burn, budget vs. actual).
- Right to information limited to protect know-how.
3.3 Conflict management
- Mediation preferred (CMAP/CEDR centers).
- Arbitration clause (ICC Paris or LCIA London) for speed and confidentiality.
4. Winning strategy: best practices
- Clear cap table and up-to-date register; avoid unidentified "passive shareholders."
- Anticipate the exit from Series A: include balanced drag-along provisions.
- Management taxation : optimize BSPCE (France) or EMI options (UK).
- Secure intellectual property before due diligence (assignment agreements & NDAs).
5. Tailored France-UK support
Our team provides expertise in:
- Fundraising structuring (Seed → Series C).
- Drafting and negotiating shareholders' agreements and financing documents.
- Legal and tax due diligence pre-investment.
- AMF / FCA compliance and regulatory filings.
Contact us to build a robust and attractive financing strategy for your investors.
Disclaimer
This information is general in nature and does not constitute legal advice. Consult a professional before making any decisions that may affect your liability.


